Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2020225773A1
Abuse-deterrent dosage forms containing esketamine
WO2020225774A1
Dosage forms for preventing drug-facilitated assault
US2020345698A1
Methods Of Treating Pruritus
WO2020222187A1
Finished fibrous structures and methods of their use and preparation
WO2020222192A1
Methods of treating pruritus
WO2020075134A1
Esketamine for use in treating major depressive disorder
AU2019352028A1
Dosage regime of esketamine for treating major depressive disorder
WO2020070706A1
Dosage regime of esketamine for treating major depressive disorder
WO2020016827A1
Purified crystalline detomidine hydrochloride monohydrate, anhydrate and free base with low amounts of iso-detomidine and other impurities by recrystallisation in water
WO2020012415A2
Topical detomidine formulations
WO2020008370A1
Transdermal patch
WO2020008366A1
Transdermal dosage form
EP3813807A1
Method of treating major depressive disorder
WO2019111132A1
Long acting gastric residence system
WO2020070547A1
Dosage regime of esketamine for treating major depressive disorder
WO2019087124A1
Finished fibrous structures and methods of their use and preparation
